about
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody produ...
Read More
9.74
0.19
(1.99%)
545.6K
XNAS Volume
XNAS 10 Jun, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Xencor Inc is on 13 Jun 2025 for the purpose of Xencor Inc Annual General Meeting for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Xencor Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..